Quanticate is pleased to announce its strategic partnership with PhaseV, a pioneer in software and machine learning (ML) for adaptive clinical trial optimization on a new technology-based service.
Quanticate, a global biometric clinical research organization (CRO), h...
Quanticate is exhibits at OCT 2023 conference.
Quanticate is pleased to announce its strategic partnership with KPS L...
Quanticate is pleased to announce that we have been selected as a fina...
Quanticate is Bronze Sponsor at this year's 31st Pharmacovigilance Con...
Quanticate, a global data-focused clinical research organization (CRO)...
We are proud to announce the launch of the new company logo as part of...
© 2024 Quanticate